Nuvilex, Inc., J & J, and Medtronic All Developing Type of Artificial pancreas

[Northerner]

While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s (otcqb:NVLX) unique cell encapsulation technology has shown it too can develop a type of "artificial pancreas" in preclinical diabetes studies. Their approaches couldn't be more different; however, all three companies are convinced that developing an artificial pancreas offers diabetics the best solution to independently monitor their blood sugar levels, and in turn, provide them with insulin when needed.

http://www.marketwatch.com/story/nu...-artificial-pancreas-for-diabetics-2013-07-02